Sofinnova Investments
Sofinnova is a life-science-focused investment firm that deploys human and financial capital to advance therapeutic drug development. The firm reports approximately $3.3B in assets under management and invests in both private and public equity, with geographic focus across the U.S. and Europe. Sofinnova targets late preclinical and clinical-stage therapeutic companies and provides company-building support, regulatory and drug-development guidance, and board-level collaboration to advance programs toward IPO and commercialization.
Sofinnova Investments
Menlo Park, California, United States, North America
Services
Financial capital deployment
Provides equity capital in private and public companies to advance therapeutic drug development.
Company building and operational support
Hands-on company-building support including strategic guidance, operational input, and board participation.
Drug development and regulatory guidance
Guidance through drug development pathways and regulatory processes to advance programs from preclinical stages to market authorization.
Public equity strategy and exit support
Provides a public equity strategy and supports company exits including IPO processes.
Financial capital deployment
Provides equity capital in private and public companies to advance therapeutic drug development.
Company building and operational support
Hands-on company-building support including strategic guidance, operational input, and board participation.
Drug development and regulatory guidance
Guidance through drug development pathways and regulatory processes to advance programs from preclinical stages to market authorization.
Public equity strategy and exit support
Provides a public equity strategy and supports company exits including IPO processes.
Portfolio
115 companies funded; 53 IPOs; 30 M&As; 31 FDA drugs approved (aggregate metrics reported by Sofinnova).
#Biopharmaceuticals / Therapeutics
115 companies funded; 53 IPOs; 30 M&As; 31 FDA drugs approved (aggregate metrics reported by Sofinnova).
#Biopharmaceuticals / Therapeutics